Dawn M ODee
Overview
Explore the profile of Dawn M ODee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
653
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Dissel J, Joosten S, Hoff S, Soonawala D, Prins C, Hokey D, et al.
Vaccine
. 2014 Dec;
32(52):7098-107.
PMID: 25454872
Here, we report on a first-in-man trial where the tuberculosis (TB) vaccine Ag85B-ESAT-6 (H1) was adjuvanted with escalating doses of a novel liposome adjuvant CAF01. On their own, protein antigens...
2.
Zinman G, Naiman S, ODee D, Kumar N, Nau G, Cohen H, et al.
Nucleic Acids Res
. 2014 Nov;
43(3):e20.
PMID: 25428368
Identifying conserved and divergent response patterns in gene networks is becoming increasingly important. A common approach is integrating expression information with gene association networks in order to find groups of...
3.
Brown M, Russo B, ODee D, Schmitt D, Nau G
Microbes Infect
. 2013 Dec;
16(4):300-9.
PMID: 24374051
Biosynthesis and acquisition of nutrients during infection are integral to pathogenesis. Members of a metabolic pathway, the glycine cleavage system, have been identified in virulence screens of the intracellular bacterium...
4.
Schmitt D, ODee D, Cowan B, Birch J, Mazzella L, Nau G, et al.
Front Cell Infect Microbiol
. 2013 Dec;
3:93.
PMID: 24367766
The highly infectious and deadly pathogen, Francisella tularensis, is classified by the CDC as a Category A bioterrorism agent. Inhalation of a single bacterium results in an acute pneumonia with...
5.
Schmitt D, ODee D, Brown M, Horzempa J, Russo B, Morel P, et al.
Microbes Infect
. 2012 Dec;
15(3):201-11.
PMID: 23211929
Pneumonic tularemia is a potentially fatal disease caused by the Category A bioterrorism agent Francisella tularensis. Understanding the pulmonary immune response to this bacterium is necessary for developing effective vaccines...
6.
Schmitt D, ODee D, Horzempa J, Carlson Jr P, Russo B, Bales J, et al.
PLoS One
. 2012 Feb;
7(2):e31172.
PMID: 22355343
Vaccination is a proven strategy to mitigate morbidity and mortality of infectious diseases. The methodology of identifying and testing new vaccine candidates could be improved with rational design and in...
7.
Zinman G, Brower-Sinning R, Emeche C, Ernst J, Huang G, Mahony S, et al.
PLoS One
. 2011 Jul;
6(7):e22401.
PMID: 21789257
Viral and bacterial infections of the lower respiratory tract are major causes of morbidity and mortality worldwide. Alveolar macrophages line the alveolar spaces and are the first cells of the...
8.
Russo B, Horzempa J, ODee D, Schmitt D, Brown M, Carlson Jr P, et al.
Infect Immun
. 2011 Jun;
79(9):3665-76.
PMID: 21670171
Tularemia is a debilitating febrile illness caused by the category A biodefense agent Francisella tularensis. This pathogen infects over 250 different hosts, has a low infectious dose, and causes high...
9.
Horzempa J, ODee D, Stolz D, Franks J, Clay D, Nau G
J Infect Dis
. 2011 Jun;
204(1):51-9.
PMID: 21628658
Francisella tularensis is the causative agent of tularemia and is classified as a category A biodefense agent by the Centers for Disease Control and Prevention because of its highly infectious...
10.
Horzempa J, ODee D, Shanks R, Nau G
Infect Immun
. 2010 Apr;
78(6):2607-19.
PMID: 20385757
The pathogenesis of Francisella tularensis has been associated with this bacterium's ability to replicate within macrophages. F. tularensis can also invade and replicate in a variety of nonphagocytic host cells,...